These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12027783)

  • 1. Morphological brain changes in depression: can antidepressants reverse them?
    Miguel-Hidalgo JJ; Rajkowska G
    CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell atrophy and loss in depression: reversal by antidepressant treatment.
    Banasr M; Dwyer JM; Duman RS
    Curr Opin Cell Biol; 2011 Dec; 23(6):730-7. PubMed ID: 21996102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.
    Sanacora G; Banasr M
    Biol Psychiatry; 2013 Jun; 73(12):1172-9. PubMed ID: 23726152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the intracellular signaling pathways affected by mood disorder treatments.
    Coyle JT; Duman RS
    Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders.
    Tsybko AS; Ilchibaeva TV; Popova NK
    Rev Neurosci; 2017 Apr; 28(3):219-233. PubMed ID: 28099138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroplasticity and depression].
    Czéh B; Simon M
    Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astroglial Connexin43 as a Potential Target for a Mood Stabiliser.
    Okada M; Oka T; Nakamoto M; Fukuyama K; Shiroyama T
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
    Sanacora G; Treccani G; Popoli M
    Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies: the missing antidepressants].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Sep; 7(3):103-4. PubMed ID: 16493873
    [No Abstract]   [Full Text] [Related]  

  • 14. New trends in the neurobiology and pharmacology of affective disorders.
    Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?
    Jeon WJ; Dean B; Scarr E; Gibbons A
    Curr Neuropharmacol; 2015; 13(6):739-49. PubMed ID: 26630954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional neuroanatomy of mood disorders.
    Soares JC; Mann JJ
    J Psychiatr Res; 1997; 31(4):393-432. PubMed ID: 9352470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting.
    Bauer M; Rasgon N; Grof P; Altshuler L; Gyulai L; Lapp M; Glenn T; Whybrow PC
    Psychiatry Res; 2005 Jan; 133(1):73-80. PubMed ID: 15698679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating mood disorders during pregnancy: safety considerations.
    Eberhard-Gran M; Eskild A; Opjordsmoen S
    Drug Saf; 2005; 28(8):695-706. PubMed ID: 16048355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.